Page last updated: 2024-08-26

artenimol and B16 Melanoma

artenimol has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fujimoto, M; Jin, G; Jin, L; Jin, Q; Li, F; Li, H; Lin, Z; Meng, F; Ren, X; Wei, Q; Yu, R	1

Other Studies

1 other study(ies) available for artenimol and B16 Melanoma

Article	Year
Dihydroartemisinin inhibits melanoma by regulating CTL/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner. Journal of dermatological science, 2020, Volume: 99, Issue:3 Topics: Administration, Oral; Animals; Apoptosis; Artemisinins; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin-10; Melanoma, Experimental; Mice; Mitochondria; Phosphorylation; Signal Transduction; Skin Neoplasms; STAT3 Transcription Factor; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Tumor Escape	2020

Article

Year

Dihydroartemisinin inhibits melanoma by regulating CTL/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner.

Journal of dermatological science, 2020, Volume: 99, Issue:3

Topics: Administration, Oral; Animals; Apoptosis; Artemisinins; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin-10; Melanoma, Experimental; Mice; Mitochondria; Phosphorylation; Signal Transduction; Skin Neoplasms; STAT3 Transcription Factor; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Tumor Escape

2020